Christophe Pierre Weber's most recent trade in Boston Scientific Corp. was a trade of 2,660 Deferred Stock Units done . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scientific | Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 2,660 | 2,660 | - | - | Deferred Stock Units | |
| Boston Scientific | Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 1,767 | 2,646 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2026 | 1,140 | 3,786 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 556 | 556 (0%) | 0% | 0 | Common Stock | |
| Boston Scientific | Christophe Pierre Weber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2026 | 323 | 879 (0%) | 0% | 0 | Common Stock |